Stopped

Stopped Trial for Bleeding Reduction With Abelacimab in AF

by
Stopped Trial for Bleeding Reduction With Abelacimab in AF

A phase 2 trial of the investigational factor severe bleeding in patients taking abelacimab versus those taking rivaroxaban. The announcement of the main results of the AZALEA-TIMI 71 trial was made by Anthos Therapeutics, the company developing abelacimab. “The AZALEA-TIMI 71 study is the largest and longest comparative study of a Factor XI inhibitor to … Read more

‘I Stopped Exercising for 18 Days, Here’s Exactly What Happened’

by
'I Stopped Exercising for 18 Days, Here's Exactly What Happened'

If you’re into exercise, chances are you’re familiar with rest days and rest weeks. They are essential to help muscles recover, replenish energy reserves and give the nervous system a break from the stress that comes with training. But more than a week and you’ll probably start worrying about losing those hard-earned gains, right? Well, … Read more